Management of Occupational and Nonoccupational HIV Exposure
Summary
- Only clinical efficacy data available for PEP come from CDC’s case-control database of exposed healthcare workers and seroconverters[Cardo 1997; Do 2003]
- Rationale for recommending PEP:
- Administration of tenofovir DF–based PEP within first 24-36 hours of vaginal exposure in macaque model prevented infection[Otten 2000]
Action required
- Login now to access all of your entitled content
or - View additional options to gain access to this content